Caredx, Inc. splits its revenue into 3 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Services at $119.2 million, 86% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
497
|
139
|
132
|
118
|
108
|
100
|
87
|
85
|
87
|
| Services |
389
+49.6%
share 78.2%
|
119
+65.2%
share 85.5%
|
100
+61.1%
share 75.7%
|
91
+47.6%
share 77.7%
|
78
+22.8%
share 72.3%
|
72
share 72.1%
|
62
share 71.6%
|
62
share 73.1%
|
64
share 73.7%
|
| Patient And Digital Solutions |
72
+39.8%
share 14.5%
|
20
+30.9%
share 14.5%
|
19
+50.1%
share 14.6%
|
16
+33.5%
share 13.6%
|
17
+47.1%
share 15.5%
|
15
share 15.4%
|
13
share 14.8%
|
12
share 14.1%
|
11
share 13.2%
|
| Product |
—
|
—
|
13
+8.1%
share 9.7%
|
10
-4.3%
share 8.8%
|
13
+16.6%
share 12.2%
|
12
share 12.5%
|
12
share 13.7%
|
11
share 12.8%
|
11
share 13.1%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- CDNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1217234
- Former names
- XDx, Inc. (until Nov 15, 2011); EXPRESSION DIAGNOSTICS INC (until Dec 14, 2005)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.